Peijia Medical Limited (HKG:9996)
Hong Kong · Delayed Price · Currency is HKD 5.90
+0.06 (1.03%)
May 11, 2026, 4:08 PM HKT
Peijia Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -203.29 | -226.58 | -392.53 | -407.81 | -574.22 |
Depreciation & Amortization | 65.23 | 56.73 | 40.2 | 33.98 | 26.33 |
Other Amortization | 2.63 | 2.33 | 2.61 | 2.03 | 1.15 |
Loss (Gain) From Sale of Assets | -0.05 | 0.37 | 0.22 | 0.03 | 0.22 |
Loss (Gain) From Sale of Investments | -9.46 | 14.98 | -4.05 | -0.58 | -0.68 |
Loss (Gain) on Equity Investments | - | - | - | 0.17 | - |
Stock-Based Compensation | 11.65 | 10.12 | 28.25 | 27.95 | 30.93 |
Other Operating Activities | 3.8 | -22.1 | -31.29 | -100.47 | 65.89 |
Change in Inventory | -0.98 | 24.66 | -44.47 | -63.06 | -40.82 |
Change in Accounts Payable | 61.75 | 94.7 | -258.97 | 193.53 | 79.36 |
Change in Unearned Revenue | - | - | - | 0.35 | -1.91 |
Change in Other Net Operating Assets | 47.84 | 39.62 | 29.11 | -62.32 | -22.62 |
Operating Cash Flow | -20.89 | -5.18 | -630.91 | -376.2 | -436.37 |
Capital Expenditures | -231.59 | -249.14 | -175.62 | -130.41 | -69.74 |
Sale of Property, Plant & Equipment | 0.4 | - | 0.25 | 0.06 | 0.01 |
Sale (Purchase) of Intangibles | -72.8 | -30.97 | -140.56 | -71.93 | -123.3 |
Investment in Securities | 26.51 | 100.86 | -42.98 | -244.08 | -224.11 |
Other Investing Activities | -40.09 | 38.87 | 20.21 | -16.92 | -7.62 |
Investing Cash Flow | -317.57 | -140.38 | -338.7 | -463.28 | -424.76 |
Long-Term Debt Issued | 270 | 53 | 146.48 | 126.69 | - |
Total Debt Issued | 270 | 53 | 146.48 | 126.69 | - |
Long-Term Debt Repaid | -92.36 | -25.54 | -59.41 | -3.37 | -3.16 |
Total Debt Repaid | -92.36 | -25.54 | -59.41 | -3.37 | -3.16 |
Net Debt Issued (Repaid) | 177.64 | 27.46 | 87.07 | 123.32 | -3.16 |
Issuance of Common Stock | 8.95 | - | 4.05 | 2.11 | 813.93 |
Repurchase of Common Stock | - | -26.69 | - | -5.18 | -64.72 |
Other Financing Activities | 25.61 | 9.6 | -6.18 | -2.81 | -4.07 |
Financing Cash Flow | 212.2 | 10.38 | 84.95 | 117.44 | 741.98 |
Foreign Exchange Rate Adjustments | -3.74 | 6.15 | 10.77 | 95.59 | -42.91 |
Net Cash Flow | -130 | -129.03 | -873.9 | -626.45 | -162.05 |
Free Cash Flow | -252.48 | -254.32 | -806.54 | -506.61 | -506.11 |
Free Cash Flow Margin | -35.42% | -41.32% | -182.84% | -201.97% | -370.68% |
Free Cash Flow Per Share | -0.38 | -0.38 | -1.19 | -0.75 | -0.77 |
Cash Interest Paid | 10.34 | 8.9 | 6.18 | 3.12 | 0.19 |
Cash Income Tax Paid | 8.23 | 7.92 | 3.44 | 9.57 | - |
Levered Free Cash Flow | -407.32 | -124.36 | -862.08 | -73.89 | -250.08 |
Unlevered Free Cash Flow | -399.98 | -121.4 | -861.97 | -72.45 | -249.96 |
Change in Working Capital | 108.61 | 158.97 | -274.32 | 68.5 | 14.01 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.